The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic BRCA2 Mutation: A Case Report

The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic BRCA2 Mutation: A Case Report

Pancreatic squamous cell carcinoma (SCC) is a rare primary pancreatic malignancy with a poor prognosis. The median overall survival (OS) for metastatic setting is only 4 months and the optimal management remains poorly defined. In the present study, we report a 52-year-old female patient with stage...

Full description

Bibliographic Details
Main Authors: Xiaozhun Huang, Chunling Wang, Teng Ma, Zhangkan Huang, Houhong Zhou, Lin Xu, Renjie Zhang, Jianjun Zhao, Yefan Zhang, Zhen Huang, Lin Shao, Yang Wang, Fan Yang, Xu Che
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
pancreatic squamous cell carcinoma
cisplatin
nanoparticle albumin-bound paclitaxel
BRCA2 mutation
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.585983/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.585983/full

Similar Items